Adenosine Tc-99m tetrofosmin SPECT in differentiation of ischemic from nonischemic cardiomyopathy in patients with LV systolic dysfunction

Clinical Nuclear Medicine

Volumn 33, Issue 7, 2008, Pages 459-463

  Her, Sung Ho ^a   Yoon, Hee Jeoung ^a   Lee, Jong Min ^a   Jin, Seung Won ^a,b   Youn, Ho Joong ^a   Seung, Ki Bae ^a   Kim, Jae Hyung ^a  

^a The Catholic University of Korea   (South Korea)

^b Daejeon St Mary's Hospital   (South Korea)

Author keywords

LV systolic dysfunction; Myocardial ischemia; Tc 99m tetrofosmin SPECT

Indexed keywords

ADENOSINE; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SYSTOLE;

AGED; CARDIOMYOPATHIES; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SYSTOLE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 52249097673     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181779271     Document Type: Article

References (25)

1. Francoise JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of left ventricular performance in heart failure. Am J Cardiol. 1981;47:33-39.
2. McKee PA, Castelli P, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971; 285:1441-1446.
3. Francoise JA, Wilen MW, Ziesche S, et al. Survival in man with severe chronic left ventricular failure due to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983;51:831-837.
4. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol. 2001;38:2101-2113.
5. Johnson LW, Lozner EC, Johnson S, et al. Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications. Cathet Cardiovasc Diagn. 1989;17:5-10.
6. Diaz RA, Nihoyannopoulos P, Athanassopoulos G, et al. Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure. Am J Cardiol. 1991;68:1224-1227.
7. Cohen A, Chauvel C, Benhalima B, et al. Is dobutamine stress echocardiography useful for noninvasive differentiation of ischemic from idiopathic dilated cardiomyopathy? Angiology. 1997;48:783-793.
8. Vigna C, Russo A, De Rito V, et al. Regional wall motion analysis by dobutamine stress echocardiography to distinguish between ischemic and nonischemic dilated cardiomyopathy. Am Heart J. 1996;131:537-543.
9. Glamann DB, Lange RA, Corbett JR, et al. Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy. Arch Intern Med. 1992;152:769-772.
10. Chiamori T, Doi YL, Yonezawa Y, et al. Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. Am J Cardiol. 1992;69:650-653.
11. Mody FV, Brunken RC, Stevenson LW, et al. Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. J Am Coll Cardiol. 1991;17:373-383.
12. Tauberg SG, Orie JE, Barthalliumett BE, et al. Usefulness of thallium-
13. for distinction of ischemic from nonischemic cardiomyopathy. Am J Cardiol. 1993;71:674-680.
14. Tian Y, Liu X, Shi R, et al. Radionuclide techniques for evaluatingdilated cardiomyopathy and ischemic cardiomyopathy. Chin Med J (Engl). 2000;113:392-395.
15. Wu Y, Yen R, Chieng P, et al. Tl-201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction. J Nucl Cardiol. 2003;10:369-374.
16. Danias PG, Papaioannou GI, Ahlberg AW, et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol. 2004;94:14-19.
17. Acampa W, Cuocolo A, Sullo P, et al. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol. 1998;5:265-274.
18. Flamen P, Bossuyt A, Franken PR. Technetium-99m tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m sestamibi. J Nucl Med. 1995;36:2009-2015.
19. Munch G, Neverve J, Matsunari I, et al. Myocardial technetium-99m tetrofosmin and technetium-99m sestamibi kinetics in normal subjects and patients with coronary artery disease. J Nucl Med. 1997;38:428-432.
20. Meller J, Goldsmith SJ, Rudin A, et al. Spectrum of exercise thallium201 myocardial perfusion imaging in patients with chest pain and normal coronary angiograms. Am J Cardiol. 1979;43:717-723.
21. Berger BC, Abramowitz R, Park CH, et al. Abnormal thallium-201 scans in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol. 1983;52:365-370.
22. Dunn RF, Wolff L, Wagner S, et al. The inconsistent pattern of thallium defects: a clue to the false positive perfusion scintigram. Am J Cardiol. 1981;48:224-232.
23. Brown KA, Osbakken M, Boucher CA, et al. Positive exercise thallium-201 test responses in patients with less than 50% maximal coronary stenosis: angiographic and clinical predictors. Am J Cardiol. 1985;55: 54-57.
24. Kaul S, Newell JB, Chesler DA, et al. Quantitative thallium imaging findings in patients with normal coronary angiographic findings and in clinically normal subjects. Am J Cardiol. 1986;57:509-512.
25. Bernhardt P, Levenson B, Albrecht A, et al. Detection of cardiac small vessel disease by adenosine-stress magnetic resonance. Int J Cardiol. 2007;121:261-266.